OUR VISION:
Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Completes 40,000 Cologuard Tests During First Quarter 2016

Revenue increases 244 percent year-over-year to $14.8 million; Commercial strategy strengthened in 2016 with television advertising campaign. MADISON, Wis., May 3, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $14.8 million during its first quarter ended March 31, 2016, an increase of 244 percent compared to $4.3 million in the...Read more

Highlights from our World Health Care Congress Panel Appearance

Exact Sciences Senior Contact Center Manager Lisa Bethke (second from left) and co-panelists at the 13th Annual World Health Care Congress One of the main challenges Exact Sciences continues to face as it moves further and further into the launch of Cologuard is a very large pool of patients with a wide variety of socioeconomic backgrounds. Indeed, reaching patients of varying backgrounds is a...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More